GUSTO bleeding criteria: Difference between revisions
Jump to navigation
Jump to search
m (GUSTO moved to GUSTO bleeding criteria) |
m (Bot: Removing from Primary care) |
||
| (7 intermediate revisions by 5 users not shown) | |||
| Line 1: | Line 1: | ||
{{ | __NOTOC__ | ||
{{Bleeding}} | |||
{{CMG}} | {{CMG}} | ||
==GUSTO Bleeding Criteria== | |||
'''Global Utilization Of Streptokinase And Tpa For Occluded Arteries''' definition for [[bleeding]] <ref name="pmid21670242">{{cite journal| author=Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J et al.| title=Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium. | journal=Circulation | year= 2011 | volume= 123 | issue= 23 | pages= 2736-47 | pmid=21670242 | doi=10.1161/CIRCULATIONAHA.110.009449 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21670242 }} </ref>, <ref name="pmid15824203">{{cite journal| author=Sabatine MS, Morrow DA, Giugliano RP, Burton PB, Murphy SA, McCabe CH et al.| title=Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. | journal=Circulation | year= 2005 | volume= 111 | issue= 16 | pages= 2042-9 | pmid=15824203 | doi=10.1161/01.CIR.0000162477.70955.5F | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15824203 }} </ref> | |||
'''Global Utilization Of Streptokinase And Tpa For Occluded Arteries''' definition for bleeding | |||
{{cquote| | {{cquote| | ||
===1. Severe or Life-threatening:=== | |||
Intracerebral hemorrhage | *[[ICH|Intracerebral hemorrhage]] | ||
Resulting in substantial hemodynamic compromise requiring treatment | *Resulting in substantial hemodynamic compromise requiring treatment | ||
===2. Moderate:=== | |||
Requiring blood transfusion but not resulting in hemodynamic compromise | *Requiring blood transfusion but not resulting in hemodynamic compromise | ||
===3. Mild=== | |||
Bleeding that does not meet above criteria }} | *[[Bleeding]] that does not meet above criteria }} | ||
== References == | ==References== | ||
{{Reflist}} | {{Reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
{{ | |||
[[Category:Medical emergencies]] | [[Category:Medical emergencies]] | ||
[[Category:Blood]] | [[Category:Blood]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
Latest revision as of 21:56, 29 July 2020
|
Bleeding Microchapters |
|
Treatment |
|---|
|
Reversal of Anticoagulation and Antiplatelet in Active Bleed |
|
Perioperative Bleeding |
|
GUSTO bleeding criteria On the Web |
|
American Roentgen Ray Society Images of GUSTO bleeding criteria |
|
Risk calculators and risk factors for GUSTO bleeding criteria |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
GUSTO Bleeding Criteria
Global Utilization Of Streptokinase And Tpa For Occluded Arteries definition for bleeding [1], [2]
| “ |
1. Severe or Life-threatening:
2. Moderate:
3. Mild
|
” |
References
- ↑ Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J; et al. (2011). "Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium". Circulation. 123 (23): 2736–47. doi:10.1161/CIRCULATIONAHA.110.009449. PMID 21670242.
- ↑ Sabatine MS, Morrow DA, Giugliano RP, Burton PB, Murphy SA, McCabe CH; et al. (2005). "Association of hemoglobin levels with clinical outcomes in acute coronary syndromes". Circulation. 111 (16): 2042–9. doi:10.1161/01.CIR.0000162477.70955.5F. PMID 15824203.